Detalhe da pesquisa
1.
Glycomacropeptide as an Efficient Agent to Fight Pathophysiological Mechanisms of Metabolic Syndrome.
Nutrients
; 16(6)2024 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38542783
2.
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders.
Antioxidants (Basel)
; 12(1)2022 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670951
3.
Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis.
Sci Rep
; 11(1): 3878, 2021 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-33594093
4.
Efficacy of Polyphenols in the Management of Dyslipidemia: A Focus on Clinical Studies.
Nutrients
; 13(2)2021 Feb 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-33669729
5.
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.
Biomedicines
; 9(9)2021 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34572325
6.
Insight into Polyphenol and Gut Microbiota Crosstalk: Are Their Metabolites the Key to Understand Protective Effects against Metabolic Disorders?
Antioxidants (Basel)
; 9(10)2020 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33066106